IRIS
PACINI, FURIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.773
EU - Europa 7.562
AS - Asia 3.679
SA - Sud America 657
AF - Africa 185
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.666
GB - Regno Unito 2.204
CN - Cina 1.343
RU - Federazione Russa 1.311
SG - Singapore 1.122
IE - Irlanda 919
IT - Italia 805
UA - Ucraina 562
BR - Brasile 528
SE - Svezia 500
VN - Vietnam 396
FR - Francia 394
DE - Germania 373
HK - Hong Kong 290
FI - Finlandia 224
KR - Corea 157
IN - India 101
ZA - Sudafrica 101
NL - Olanda 75
BD - Bangladesh 54
CA - Canada 51
AR - Argentina 48
TR - Turchia 47
ES - Italia 35
MX - Messico 31
BE - Belgio 29
PL - Polonia 29
IQ - Iraq 28
JP - Giappone 26
MA - Marocco 20
VE - Venezuela 18
NG - Nigeria 17
AT - Austria 16
PK - Pakistan 15
EC - Ecuador 14
PY - Paraguay 14
CL - Cile 13
AU - Australia 12
CZ - Repubblica Ceca 11
TN - Tunisia 11
UZ - Uzbekistan 11
KE - Kenya 10
CH - Svizzera 9
CO - Colombia 9
SA - Arabia Saudita 9
EU - Europa 8
JO - Giordania 8
LT - Lituania 8
BG - Bulgaria 7
CI - Costa d'Avorio 7
ID - Indonesia 7
IR - Iran 7
JM - Giamaica 7
OM - Oman 7
AL - Albania 6
GR - Grecia 6
IL - Israele 6
NP - Nepal 6
PT - Portogallo 6
RO - Romania 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
EG - Egitto 5
HU - Ungheria 5
LB - Libano 5
NZ - Nuova Zelanda 5
PA - Panama 5
BO - Bolivia 4
EE - Estonia 4
PH - Filippine 4
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KZ - Kazakistan 3
MD - Moldavia 3
PE - Perù 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CR - Costa Rica 2
CU - Cuba 2
DK - Danimarca 2
ET - Etiopia 2
LV - Lettonia 2
MY - Malesia 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
GH - Ghana 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
Totale 21.870
Salva come PNG Salva come JPEG
Città #
Southend 2.031
Fairfield 1.241
Dublin 901
Dallas 859
Ashburn 705
Woodbridge 586
Chandler 581
Singapore 559
Wilmington 468
Seattle 453
Jacksonville 452
Santa Clara 447
Houston 439
Cambridge 399
Beijing 341
Moscow 326
San Jose 296
Ann Arbor 286
Hong Kong 276
Siena 275
The Dalles 179
Hefei 158
Seoul 154
Nanjing 153
Princeton 147
Los Angeles 144
Helsinki 112
Ho Chi Minh City 103
Lauterbourg 96
Johannesburg 87
Hanoi 85
New York 85
Boardman 81
Council Bluffs 73
Munich 66
San Diego 65
Dong Ket 56
Nanchang 55
Buffalo 51
Amsterdam 47
São Paulo 45
Saint Petersburg 40
San Mateo 40
Milan 39
London 38
Shanghai 38
Florence 37
Düsseldorf 36
Tianjin 31
Turku 30
Orem 29
Shenyang 29
Chicago 28
Brussels 27
Kunming 27
Chennai 26
Jiaxing 26
Lancaster 26
Changsha 25
Columbus 25
Guangzhou 25
Hebei 24
Frankfurt am Main 23
Washington 22
Izmir 21
Jinan 21
Prato 20
Dearborn 19
Tokyo 19
Zhengzhou 19
Norwalk 18
Phoenix 18
Redwood City 18
Abuja 17
Brooklyn 17
Haiphong 17
Montreal 17
Redondo Beach 17
Warsaw 17
Denver 16
Málaga 15
Ningbo 15
San Francisco 15
Belo Horizonte 14
Rome 14
Da Nang 13
Renton 13
Ankara 12
Biên Hòa 12
Brasília 12
Hangzhou 12
Manchester 12
Rio de Janeiro 12
Venezia 12
Bengaluru 11
Atlanta 10
Baghdad 10
East Falmouth 10
Nairobi 10
Stockholm 10
Totale 15.189
Salva come PNG Salva come JPEG
Nome #
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer 478
null 398
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 371
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 345
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 323
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 319
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 319
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 311
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 296
Reference range of serum calcitonin in pediatric population 295
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 294
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 292
Approach to and treatment of differentiated thyroid carcinoma 286
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer 286
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 279
Acute exogenous TSH administration stimulates leptin secretion in vivo 274
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma 274
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 265
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 263
Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB) 250
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question 249
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 244
Definition and management of radioactive iodine-refractory differentiated thyroid cancer 239
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment 239
Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer 238
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 238
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 237
Management of thyroid nodules: a clinicopathological, evidence-based approach 235
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 234
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 231
Changing natural history of differentiated thyroid cancer 230
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 223
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancer 223
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update 223
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab 222
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 219
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 218
Management of papillary thyroid microcarcinoma: primum non nocere! 217
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 216
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 215
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 214
Medullary thyroid carcinoma 214
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone 209
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 205
Ernest L. Mazzaferri, MD, MACP (1936-2013) 203
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 203
Serum Ghrelin As a Marker of Atrophic Body Gastritis in Patients With Parietal Cell Antibodies 202
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 201
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 201
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up 198
Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients 197
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 196
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? 193
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 193
H. pylori (hp) infection and autoimmune diseases (ad): prevalence of infection in patients with Hashimoto's thyroiditis (ht) and allignement of thyroid hormones (th) with H. pylori proteins. 191
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 191
Best practice & research clinical endocrinology & metabolism. Thyroid nodules and cancer. Preface 190
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 190
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 189
Post-thyroidectomy chronic asthenia: self-deception or disease? 186
Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer 186
Screening of thyroid nodules by serum calcitonin measurements: why not? 185
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 184
Management of differentiated thyroid cancer of the follicular epithelium 183
Observation for newly diagnosed micro-papillary thyroid cancer: is now the time? 180
Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis 180
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 180
Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions 179
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 179
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology 178
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 176
Multinodular goiter of unusual shape and location 175
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis 175
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer 174
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal 172
How Far Should We Go in the Search and Treatment of Recurrent or Persistent Lymph Node Metastases during Follow-Up of Thyroid Cancer Patients? 169
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 169
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 169
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 168
Telomeres and thyroid cancer 167
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 165
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 165
The low utility of pretherapy scans in thyroid cancer patients 163
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 163
Radioiodine therapy in the different stages of differentiated thyroid cancer 161
New insight in the follow-up strategies of differentiated thyroid cancer 161
Management of advanced medullary thyroid cancer 160
Targeted therapy in refractory thyroid cancer: current achievements and limitations 159
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study 158
Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian Syndrome 156
Rare diseases in clinical endocrinology: a taxonomic classification system 155
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium 154
Medullary thyroid cancer: management guidelines of the American Thyroid Association 153
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 153
Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand 151
Thyroid microcarcinoma 147
Manuale di medicina interna 139
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 138
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer 137
null 126
Totale 21.366
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.093
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021180 0 0 0 0 0 0 0 0 0 0 0 180
2021/20221.267 132 183 69 94 68 51 62 41 81 141 141 204
2022/20231.929 113 171 256 267 193 378 38 169 211 32 72 29
2023/20241.243 67 30 106 39 52 348 455 19 6 18 16 87
2024/20252.822 54 137 241 138 385 196 96 140 237 96 393 709
2025/20265.973 525 908 623 725 1.047 290 694 212 237 298 205 209
Totale 22.072